US Broker Ratings

Yalla Group Limited (YALA) Stock Analysis: Exploring a 32% Potential Upside for Tech Investors

Yalla Group Limited (NYSE: YALA), a prominent player in the technology sector, is catching the eye of investors with its intriguing growth prospects and significant potential upside. Headquartered in Dubai,..

Uber Technologies, Inc. (UBER): Investor Outlook as Analysts See 17.70% Upside Potential

Uber Technologies, Inc. (NYSE: UBER) stands as a formidable player in the technology sector, particularly within the software application industry. With a substantial market capitalization of $192.3 billion, Uber is..

WERIDE INC. (WRD) Stock Analysis: Navigating the Autonomous Driving Frontier with a 68.75% Potential Upside

WeRide Inc. (NASDAQ: WRD), a prominent player in the autonomous driving sector, presents a compelling proposition for investors seeking exposure to cutting-edge technology with robust growth potential. As a leader..

A2Z Cust2Mate Solutions Corp. (AZ) Stock Analysis: Exploring a 206% Upside Potential in Retail Technology

A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ), a burgeoning player in the technology sector, is making waves with its innovative approach to retail solutions. With a market capitalization of $273.15 million,..

Health Catalyst, Inc (HCAT) Stock Analysis: A 37% Potential Upside in Healthcare Analytics

Health Catalyst, Inc. (NASDAQ: HCAT), a prominent player in the health information services sector, has been making waves with its innovative approach to data and analytics technology for healthcare organizations..

Viemed Healthcare, Inc. (VMD): Investor Outlook with a Potential 90% Upside

Viemed Healthcare, Inc. (VMD) stands as a compelling prospect for investors seeking exposure in the healthcare sector, particularly in the burgeoning field of medical devices. With a market capitalization of..

Shopify Inc. (SHOP) Stock Analysis: Unpacking the $210 Billion E-commerce Giant’s Growth Story

Shopify Inc. (NYSE: SHOP), the Canadian e-commerce powerhouse, has seen its market capitalization soar to a staggering $210 billion, underscoring its formidable presence in the software application industry. As a..

Candel Therapeutics, Inc. (CADL) Stock Analysis: A 263.93% Potential Upside in the Biotech Arena

Candel Therapeutics, Inc. (NASDAQ: CADL), a pioneering clinical-stage biopharmaceutical company, is at the forefront of developing innovative immunotherapies for cancer treatment. Based in Needham, Massachusetts, the company is making significant..

Kaltura, Inc. (KLTR) Investor Outlook: A Look at Nearly 97% Upside Potential Amidst Industry Challenges

Kaltura, Inc. (KLTR), a prominent player in the software-as-a-service (SaaS) and platform-as-a-service (PaaS) sectors, is capturing investor attention with its substantial upside potential. Despite facing challenges typical of tech companies,..

Alpha Tau Medical Ltd. (DRTS) Stock Analysis: Exploring a 110% Potential Upside in Biotechnology

Alpha Tau Medical Ltd. (NASDAQ: DRTS) is drawing attention in the biotechnology sector with its promising clinical-stage oncology therapies and a compelling potential upside of 110.40%. As a company headquartered..

Fastly, Inc. (FSLY) Stock Analysis: Navigating Growth in the Edge Cloud Market

Fastly, Inc. (NYSE: FSLY) stands at the forefront of the edge cloud platform industry, offering innovative solutions to enhance the speed, security, and reliability of digital experiences. With a market..

Phathom Pharmaceuticals (PHAT) Stock Analysis: Exploring a Biotech with 58.80% Potential Upside

Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) is capturing the attention of investors with its significant potential upside and promising product pipeline in the biotech sector. With a market capitalization of approximately..

HubSpot, Inc. (HUBS) Stock Analysis: Exploring the 46.51% Potential Upside

HubSpot, Inc. (NYSE: HUBS), a prominent player in the technology sector, is capturing the attention of investors with its impressive potential upside. With a market capitalization of $24.74 billion, HubSpot..

Cytek Biosciences, Inc. (CTKB) Stock Analysis: Navigating a 24.7% Potential Upside in the Medical Devices Sector

Cytek Biosciences, Inc. (NASDAQ: CTKB), a leader in the healthcare sector specializing in innovative medical devices, is catching the eye of investors with its compelling position in the cell analysis..

Nyxoah SA (NYXH) Stock Analysis: Exploring a 120% Upside Potential in the Sleep Apnea Market

Investors seeking innovative opportunities in the healthcare sector might find Nyxoah SA (NASDAQ: NYXH) an intriguing prospect. Situated in the medical instruments and supplies industry, Nyxoah is a Belgium-based company..

SANUWAVE Health, Inc. (SNWV) Stock Analysis: Exploring a 70% Upside Potential in the Growing Medical Device Sector

For investors keen on the healthcare sector, SANUWAVE Health, Inc. (NASDAQ: SNWV) presents a compelling opportunity with a forecasted upside of over 70%. As a provider of innovative medical devices,..

ZoomInfo Technologies Inc. (GTM) Stock Analysis: A 7% Upside Potential Amidst Mixed Ratings

ZoomInfo Technologies Inc. (NASDAQ: GTM), a prominent player in the technology sector, specializes in providing a comprehensive go-to-market intelligence platform that serves a myriad of professionals across sales, marketing, operations,..

Pacific Biosciences of California (PACB) Stock Analysis: Healthcare Innovator with a Potential 17% Upside

Pacific Biosciences of California, Inc. (NASDAQ: PACB), an innovator in the healthcare sector, is carving a niche in the medical devices industry with its unique sequencing solutions. Despite the company’s..

AudioEye, Inc. (AEYE) Stock Analysis: Exploring a 64% Upside in the Digital Accessibility Market

For investors seeking exposure in the burgeoning digital accessibility market, AudioEye, Inc. (NASDAQ: AEYE) presents a compelling opportunity backed by significant growth potential. With a market capitalization of $167.63 million,..

Cartesian Therapeutics, Inc. (RNAC) Stock Analysis: A Biotech with Over 300% Potential Upside

Cartesian Therapeutics, Inc. (NASDAQ: RNAC) is a clinical-stage biotechnology company that has caught the attention of investors with its promising pipeline and substantial potential upside of over 300%. Specializing in..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds